TradeFlare's AI research teams analysed HIMS on 10 market nights between April 21, 2026 and August 24, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| August 24, 2026 | HOLD | $33.78 | — / — | -4.8% | -2.1% | Post-earnings drift signal from scanner. |
| August 22, 2026 | HOLD | $33.78 | — / — | -4.8% | -2.1% | The scanner trigger suggests a short-term post-earnings drift opportunity. |
| July 23, 2026 | HOLD | $31.68 | — / — | -17.4% | -2.7% | The stock is currently in a neutral market regime and the team scorecard indicates a bearish fundamental outlook and high risk, overriding the technical scanner trigger. |
| July 22, 2026 | BUY | $32.73 | — / — | -21.1% | -1.9% | Potential positive outcome from upcoming FDA peptide meeting. |
| June 24, 2026 | BUY | $32.96 | — / — | +14.9% | +0.1% | Post-earnings drift signal from scanner. |
| June 23, 2026 | BUY | $33.54 | — / — | +5.2% | -3.9% | The stock is currently at a resistance level and the technicals are neutral, indicating a lack of immediate upside potential. |
| June 22, 2026 | BUY | $35.47 | — / — | -0.5% | -2.4% | Continued positive sentiment and growth in the GLP-1 market. |
| June 19, 2026 | HOLD | $35.47 | — / — | -0.5% | -2.4% | Post-earnings drift signal from scanner. |
| May 27, 2026 | BUY | $23.85 | — / — | +9.2% | +29.8% | The current market regime and stock-specific factors do not support a new trade. |
| April 21, 2026 | HOLD | $31.01 | — / — | -6.2% | -24.6% |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.